Today’s Market Winners and Losers

Once again, concerns over European debt is sending stocks tumbling. The Dow is down 0.61%, the Nasdaq is down 0.39% and the S&P 500 is down 0.62%. There were a ton of high volume winners and losers today, so many that 24/7 Wall St. had to limit the winners and losers to three each. Today’s winners include a drug maker announcing strong results for a muscular dystrophy drug, while the other two winners reported earnings beating analyst expectations. Meanwhile, weak earnings or weak projections brought down all of the big losers.

Here are Tuesday’s market winners and losers.

Biggest Winners

Shares of Sapeta Therapeutics (NASDAQ: SRPT) are up 136.99% to $8.20 on trading volume of 6.6 million shares. The company has announced strong results from eteplirsen, which is intended to improve walking for patients with muscular dystrophy. The 52-week high is $9.96.

Shares of Baidu (NASDAQ: BIDU) are up 11.48% to $119.40 on trading volume 7.8 million shares. The Chinese Internet search engine reported a 51.5% higher operating profit compared to the year-earlier period. The 52-week high is $165.96.

Shares of Under Armour (NYSE: UA) are up 11.95% to $54.16 on trading volume of 4.7 million shares. The athletic apparel maker reported net earnings of 6 cents a share, better than 5 cents a share expected on Wall Street. Before Tuesday, the 52-week high was $53.93

Biggest Losers

Shares of DeVry (NYSE: DV) are down 27.29% to $20.04 on trading volume of 5.2 million shares. DeVry announced Monday that it expects to earn 43 cents to 46 cents in the fourth-quarter, well below the 79 cents wall street analysts were expecting. Before Tuesday, the 52-week low was $26.13.

Shares of Gentex (NASDAQ: GNTX) are down 22.08% to $16.48 on trading volume of 8 million shares.  The company posted earnings of 28 cents a share, down from the 29 cents a share analysts were expecting. Before Tuesday, the 52-week low was $19.36.

Shares of WebMD (NASDAQ: WBMD) are down 20.76% to $14.20 on trading volume of 2.9 million shares. The health care information company said it projects a second-quarter loss of $6 million. Losses for the year are expected to be between $11.9 million and $22.9 million. Before Tuesday, the 52-week low was $17.88.

Samuel Weigley